Le Lézard
Classified in: Health
Subjects: LBR, AVO

Unifor welcomes pay increase for CCAs in Nova Scotia


HALIFAX, NS, Feb. 9, 2022 /CNW/ - Unifor welcomes the news today that Nova Scotia will be increasing the rate of pay for Continuing Care Assistants (CCAs) in the province by more than 20% as of tomorrow.

"After many years of trying to communicate the level of pressure CCAs are under in our long-term care homes due to short-staffing and low wages, it is a relief for so many of our members to feel seen and respected today," said Linda MacNeil, Unifor Atlantic Regional Director. "CCAs deserve this raise and recognition of the vital role they play in caring for residents of long-term care through everyday challenges particularly through this pandemic."

Unifor represents more than 2,000 workers across the province in long-term care and has long advocated for changes to increase worker recruitment and retention to create safer and healthier working and living conditions across the sector.

"We are thankful this government has acted swiftly to address the single biggest issue in recruiting and retaining CCAs in this province, which was their compensation," said MacNeil. "CCAs are like family to long-term care residents and provide more than just health care, but companionship and emotional support as well. We are hopeful this news makes many families happier tonight."

Unifor is Canada's largest union in the private sector and represents 315,000 workers in every major area of the economy, including more than 30,000 in the health care sector nationally. The union advocates for all working people and their rights, fights for equality and social justice in Canada and abroad, and strives to create progressive change for a better future.

SOURCE Unifor


These press releases may also interest you

at 03:20
Calliditas Therapeutics AB (STO: CALTX) ("Calliditas") today announces that its partner Viatris Pharmaceutical Japan G.K. ("Viatris") has initiated a phase III clinical trial in Japan with Nefecon, named VR-205 in the Japanese market, in Japanese...

at 03:00
Global biotechnology leader CSL Behring today announced that two hemophilia B patients were treated with the gene therapy HEMGENIX® (etranacogene dezaparvovec) at Hemophilia Treatment Centers in France. This milestone achievement makes HEMGENIX® the...

at 02:30
SOPHiA GENETICS , a cloud-native healthcare technology company and a global leader in data-driven medicine, today announced that Dhiti Omics Technologies, a precision molecular diagnostics service provider in India, is live on the SOPHiA...

at 01:15
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the Phase II/III SKYSCRAPER-06 study, evaluating tiragolumab plus Tecentriq® (atezolizumab) and chemotherapy versus pembrolizumab and chemotherapy as an initial...

at 01:05
BenevolentAI ("BenevolentAI" or the "Company") (Euronext Amsterdam: BAI), a leader in applying advanced AI to accelerate biopharma drug discovery, announces the appointment of Deutsche Numis as the Company's Financial and Capital Markets Adviser,...

3 jui 2024
YOUR LEGAL RIGHTS MAY BE AFFECTED There is a proposed settlement in a class-action lawsuit filed against Pfizer Inc., Pfizer Ireland Pharmaceuticals, Warner-Lambert Company, and Warner-Lambert Company LLC (collectively, "Pfizer") and Ranbaxy Inc.,...



News published on and distributed by: